UPC Analytics
ENDE
Overview · Filed:

UPC_APP_4496/2025

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

Procedural & sub-applicationsOther ProceduralDusseldorf LDGeneric application
Parties

Claimants

  • GlaxoSmithKline Biologicals SA
Reps: Oliver Jan Jüngst (Bird & Bird LLP); Luca Brons (Bird & Bird LLP)

Respondents

  • Pfizer Europe MA EEIG
  • Pfizer Manufacturing Belgium NV
  • Pfizer Pharma GmbH
  • Pfizer Corporation Austria GmbH
  • Pfizer S.A.
  • Pfizer Aps
  • Pfizer Oy
  • Pfizer SAS
  • Pfizer S.r.l.
  • Pfizer B.V.
  • Laboratórios Pfizer, Lda.
  • Pfizer AB
  • Pfizer Luxembourg S.a.r.l.
  • Pfizer Service Company S.R.L.
Reps: Gareth Williams (Marks & Clerk LLP); Claudia Milbradt (Clifford Chance Partnerschaft mbB); Tobias J. Hessel (Clifford Chance Partnerschaft mbB)
Judges
  • Ronny ThomasPresiding judge
  • Jule Kathrin SchumacherLegally qualified judge and judge-rapporteur
  • PostiglioneLegally qualified judge
Patents
  • EP4183412
CPC codes: C12N2760/18522, C12N2760/18534, A61K2039/55505, A61K2039/5258, A61K2039/55566, A61K39/155, A61K39/12, C07K2319/73, A61K2039/53, C07K2317/76, A61P31/14, A61P37/04

Sector: Biotechnology

Outcome
Procedural only
Filed:
First decided: Mar 4, 2025
Language: